Failed to manage credit risk? What are you talking about. I strongly recommend that you go back and read the 10K from 2012 and then you start to understand the Transformation from old DECN to the new DECN due to the FDA Approval for their Genstrip.
DECN started with the production of Genstrip only in summer 2013.
Either you do not want to undertstand, then you are excused or you do what you have been doing since you started bash the Company when the stock was in the low 20s.
Here again for beginners:
Decision Diagnostics Corp. News
November 2013
•
Diabetes: J&J loses a round in glucose testing battle with Shasta (Nov 7)
•
Decision Diagnostics On Track For Growth And Increased Revenues (Nov 7)
•
DECN And Pharma Tech Solutions Receive Anticipated Ruling From The U.S. Federal Circuit Court Of Appeals, Reversing A Ruling By Lower Court Judge (Nov 5)
•
DECN Wins Only Case That Matters in Federal Circuit Court (.pdf) (Nov 4)
October 2013
•
Well Ahead Of Schedule, Decision Diagnostic's Pharma Tech Division Completes First Major Shipments Of Its Popular Genstrip Test Strip (Oct 31)
•
Decision Diagnostics Receives Signed Term Sheet Agreement For $12.5 Million Revolving Credit Facility Which Will Complete DECN’s GenStrip Roll-Out Plan (Oct 29)
•
Decision Diagnostics Could Be The New Vringo (Oct 24)
•
Recognized Healthcare And Financial Publications Acknowledge Decision Diagnostics’ GenStrip Market Potential (Oct 22)
•
DECN Set To Climb As GenStrip Enters Blood Glucose Monitoring Market With First Shipments (Oct 22)
•
Decision Diagnostic Blood Glucose Test Strip Technology Enters Market with Genstrip (Oct 22)
•
Court Ruling for Decision Diagnostics Order Staying Proceedings (.pdf) (Oct 9)
•
Decision Diagnostics' Pharma Tech Division Schedules Shipments For Its Popular GenStrip Test Strip (Oct 3)
•
Decision Diagnostics' Pharma Tech Division Schedules Large Order Shipments for Its Popular GenStrip Test Strip (Oct 1)
September 2013
•
David And Goliath Case Offers A Surprising Opportunity (Sep 26)
•
J&J feels Decision Diagnostics' sting in glucose strip patent fight (Sep 12)
•
J&J's Blood Sugar Testing Patent Spat Turns Sour (Sep 12)
•
J&J Seeks Court Aid To Protect Its Glucose Monitoring Test (Sep 11)
•
Decision Diagnostics Corp. Announces Completion and Airing of Its New Genstrip Video Titled "A Patchwork of Life" (Sep 10)
•
Decision Diagnostic's GenStrip Could Change the Blood Glucose Market (Sep 1)
August 2013
•
Court's Ruling on PharmaTech's Motion for Contempt (Aug 28)
•
GenStrip™ and USPTO Ruling (Aug 15)
•
Decision Diagnostics Subsidiary Makes Move and Sues Two Johnson and Johnson Divisions for False Advertising in Ongoing Battle (Aug 1)
May 2013
•
DECN Steps Into Role of White Knight by Offering Strategic Version of GenStrip™ Exclusively for Medicare Competitive Bidding Program (May 29)
•Decision Diagnostics Corp. is saddened to announce the sudden passing of our long-time friend and Computer and Information Systems Manager, Mr. Alan B Binder (May 10)
April 2013
•
Decision Diagnostics Corp. and Its Subsidary PharmaTech Solutions Seek to End Pharma Giant's Alleged Restraint of Trade Tactics (Apr 5)
•
Decision Diagnostics Corp. and Its Subsidiary PharmaTech Solutions, Inc. Sue Johnson & Johnson Division LifeScan, Inc. and LifeScan Scotland Ltd. for Antitrust Violations (Apr 4)
March 2013
•
J&J Faces Potentially Disrupting Competition In Its Lucrative Glucose Monitoring Business From Tiny Diagnostics Outfit (Mar 11)
January 2013
•
FDA Review - Decision Summary (Jan 2)
•
FDA 510(k) Premarket Notification (Jan 2)
December 2012
•
FDA 510(K) Clearance Letter (Dec 5)
•
Opportunity and Market for Decision Diagnostics (OTCBB:DECN) Shasta GenStrip®; at home diagnostic for testing blood glucose (Dec 4)
News 
Market Data 
Discover 
AI
